Prolong Pharmaceuticals
Ron Jubin is the VP of R&D at Prolong Pharmaceuticals. Ron has over 20 years of experience in the pharmaceutical industry, including leading the R&D department at PBL InterferonSource and working as a scientist at Schering-Plough Research Institute. Ron is a skilled researcher and scientists, and has been instrumental in developing new products and processes at Prolong Pharmaceuticals. Ron is a respected leader in the industry, and their work has helped Prolong Pharmaceuticals to become a leading manufacturer of innovative drugs and therapies.
Ron Jubin has a Ph.D. in Microbiology and Molecular Genetics from Rutgers Robert Wood Johnson Medical School (UMDNJ). Ron's research focuses on the host response to viruses. Ron also has a M.S. in Microbiology from Seton Hall University and a B.A. in Microbiology from Kean University.
Ron Jubin reports to Nikunj Patel, President. Some of their coworkers include John Pakulski - SVP, Regulatory, Chandra Rawal - Head Of Operations.
This person is not in any offices
Prolong Pharmaceuticals
Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing products to treat several diseases and their debilitating comorbidities which cause reduced quality of life, increased medical costs and significant mortality.